Analyst consensus target prices ticked higher across energy and mining names this week. The moves are modest but consistent — a signal of quiet confidence in the sector.
TRGP saw its average analyst target rise to $283.50. The midstream giant carries a $54.7bn market cap and has 19 buy ratings with zero sells. Short interest sits at just 2.1% of free float. Analysts are firmly on the same side.
DVN also got a target bump, to $61.24. Devon Energy holds a $51.3bn market cap. All 20 buy-side analysts remain positive. Short sellers have a thin 2.4% position — not a crowd betting against the stock.
Gold miner NEM moved up too, with the consensus target edging to $143.05. Newmont's market cap now stands at $117bn. Eighteen analysts back the stock. Gold's recent strength is likely driving the optimism.
Meanwhile, the medical devices sector saw a wave of recommendation removals. MDT, EW, BSX, , and all had analyst recs pulled. saw its target trimmed slightly to $389.24. The medtech cleanup may reflect post-earnings model resets rather than sentiment shifts.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
